Cardiac hypertrophy determines digitalis action on intracellular Ca2+ in human myocardium

Jose R. Lopez, Nancy Linares, Peter A. Brady, Andre Terzic

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Ventricular hypertrophy alters transporters associated with digitalis action, but the outcome of digitalis treatment on intracellular cations in the hypertrophied human myocardium remains unknown. Using double-barreled Ca2+-selective microelectrodes, we simultaneously measured Ca2+ activity and membrane potential in myocardial samples from patients without and with ventricular hypertrophy, prior to and following exposure to strophanthidin, a prototype digitalis. We found that ventricular hypertrophy is associated with greater strophanthidin-induced increase in diastolic Ca2+ levels compared to that observed in the absence of hypertrophy. Furthermore, in hypertrophied myocardium the magnitude of the increase in Ca2+ induced by strophanthidin was inversely related to increase in myocardial mass. Thus, the extent of ventricular hypertrophy determines digitalis action on intracellular Ca2+ within the human myocardium.

Original languageEnglish (US)
Pages (from-to)161-164
Number of pages4
JournalEuropean Journal of Pharmacology
Volume339
Issue number2-3
DOIs
StatePublished - Nov 27 1997

Fingerprint

Digitalis
Cardiomegaly
Strophanthidin
Hypertrophy
Myocardium
Microelectrodes
Membrane Potentials
Cations

Keywords

  • Ca level
  • Diastolic
  • Ion-selective microelectrode
  • Ventricular mass

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Cardiac hypertrophy determines digitalis action on intracellular Ca2+ in human myocardium. / Lopez, Jose R.; Linares, Nancy; Brady, Peter A.; Terzic, Andre.

In: European Journal of Pharmacology, Vol. 339, No. 2-3, 27.11.1997, p. 161-164.

Research output: Contribution to journalArticle

Lopez, Jose R. ; Linares, Nancy ; Brady, Peter A. ; Terzic, Andre. / Cardiac hypertrophy determines digitalis action on intracellular Ca2+ in human myocardium. In: European Journal of Pharmacology. 1997 ; Vol. 339, No. 2-3. pp. 161-164.
@article{e02c0d4284614949951bc563c49cd458,
title = "Cardiac hypertrophy determines digitalis action on intracellular Ca2+ in human myocardium",
abstract = "Ventricular hypertrophy alters transporters associated with digitalis action, but the outcome of digitalis treatment on intracellular cations in the hypertrophied human myocardium remains unknown. Using double-barreled Ca2+-selective microelectrodes, we simultaneously measured Ca2+ activity and membrane potential in myocardial samples from patients without and with ventricular hypertrophy, prior to and following exposure to strophanthidin, a prototype digitalis. We found that ventricular hypertrophy is associated with greater strophanthidin-induced increase in diastolic Ca2+ levels compared to that observed in the absence of hypertrophy. Furthermore, in hypertrophied myocardium the magnitude of the increase in Ca2+ induced by strophanthidin was inversely related to increase in myocardial mass. Thus, the extent of ventricular hypertrophy determines digitalis action on intracellular Ca2+ within the human myocardium.",
keywords = "Ca level, Diastolic, Ion-selective microelectrode, Ventricular mass",
author = "Lopez, {Jose R.} and Nancy Linares and Brady, {Peter A.} and Andre Terzic",
year = "1997",
month = "11",
day = "27",
doi = "10.1016/S0014-2999(97)01398-8",
language = "English (US)",
volume = "339",
pages = "161--164",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Cardiac hypertrophy determines digitalis action on intracellular Ca2+ in human myocardium

AU - Lopez, Jose R.

AU - Linares, Nancy

AU - Brady, Peter A.

AU - Terzic, Andre

PY - 1997/11/27

Y1 - 1997/11/27

N2 - Ventricular hypertrophy alters transporters associated with digitalis action, but the outcome of digitalis treatment on intracellular cations in the hypertrophied human myocardium remains unknown. Using double-barreled Ca2+-selective microelectrodes, we simultaneously measured Ca2+ activity and membrane potential in myocardial samples from patients without and with ventricular hypertrophy, prior to and following exposure to strophanthidin, a prototype digitalis. We found that ventricular hypertrophy is associated with greater strophanthidin-induced increase in diastolic Ca2+ levels compared to that observed in the absence of hypertrophy. Furthermore, in hypertrophied myocardium the magnitude of the increase in Ca2+ induced by strophanthidin was inversely related to increase in myocardial mass. Thus, the extent of ventricular hypertrophy determines digitalis action on intracellular Ca2+ within the human myocardium.

AB - Ventricular hypertrophy alters transporters associated with digitalis action, but the outcome of digitalis treatment on intracellular cations in the hypertrophied human myocardium remains unknown. Using double-barreled Ca2+-selective microelectrodes, we simultaneously measured Ca2+ activity and membrane potential in myocardial samples from patients without and with ventricular hypertrophy, prior to and following exposure to strophanthidin, a prototype digitalis. We found that ventricular hypertrophy is associated with greater strophanthidin-induced increase in diastolic Ca2+ levels compared to that observed in the absence of hypertrophy. Furthermore, in hypertrophied myocardium the magnitude of the increase in Ca2+ induced by strophanthidin was inversely related to increase in myocardial mass. Thus, the extent of ventricular hypertrophy determines digitalis action on intracellular Ca2+ within the human myocardium.

KW - Ca level

KW - Diastolic

KW - Ion-selective microelectrode

KW - Ventricular mass

UR - http://www.scopus.com/inward/record.url?scp=0031588407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031588407&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(97)01398-8

DO - 10.1016/S0014-2999(97)01398-8

M3 - Article

C2 - 9473131

AN - SCOPUS:0031588407

VL - 339

SP - 161

EP - 164

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -